Review of Article: Yahyavi et al. Benefits of glucagon-like peptide (GLP)-1 receptor agonists on 5-year risk of major amputation, all-cause mortality, myocardial infarction, and ischemic stroke in patients with chronic limb-threatening ischemia. Vasc Med. 2026;31(1):719–727

Journal of Vascular Nursing · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles